In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to EAPC Ivory (& above) Members, Fellows of the ESC and Young combined Members

Prognosis masked hypertension in five years

Session Poster Session III - Friday 08:30 - 12:30

Speaker Anna Miroshnichenko

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Topic : hypertension
  • Sub-topic : Hypertension
  • Session type : Poster Session

Authors : I Osipova (Barnaul,RU), A Miroshnichenko (Barnaul,RU), O Antropova (Barnaul,RU), N Pyrikova (Barnaul,RU), A Zaltsman (Barnaul,RU)

I Osipova1 , A Miroshnichenko2 , O Antropova1 , N Pyrikova1 , A Zaltsman2 , 1Altay State Medical University - Barnaul - Russian Federation , 2Railway Clinical Hospital - Barnaul - Russian Federation ,


Objective: explore prognosis masked hypertension in men with occupational stress without cardiovascular disease (CVD).

Materials and Methods: A total of 99 drivers and their assistants. Conducted identification of hypertension and masked hypertension. The survey was conducted at intervals of five years. The masked hypertension determined from the stress test "Mathematical expense." The test was positive for growth in systolic blood pressure (sBP) > 7% and/or increment of heart rate > 10%. Identified 2 groups: the first group - a man with a masked hypertension (n = 40, age 42,8 ± 9,8 years); 2nd group - men with normal blood pressure (BP) (n = 59, age 42,3 ± 8,4 years).

Results: In both groups, according to stress test a marked rise in BP and heart rate. The highest values ??of BP and heart rate were the men of the 1st group. Important growth indicators, since it was he who reflects stress reactivity examined. In men, the first group compared with the second stress test on the increase sBP was 2.2 times higher (p < 0,001) increase in heart rate 2.3 times higher (p < 0,001). Increase in diastolic BP (dBP) in the 1st group was higher by 24% (p < 0,05). Risk factors in the 1st group compared with the second: a history of CVD met 2,2 times more often (?2 = 9,22, p < 0,002) (58% in the 1st group and 27% in the 2nd group); smoking status 1,8 times more often (frequency 77,5%) (?2 = 11,9, p < 0,0005); abdominal obesity is 2,3 times more often (?2 = 6,69, p < 0,001) (42.4% in the 1st group and 18.6% in the 2nd group); Hypercholesterolemia was defined more by 2,3 times (?2 = 10,07, p < 0,001) and was 55%.

After 5 years, have been re-examination of the two groups of men with a diagnosis of hypertension and masked hypertension. For 5 years, hypertension was detected in 25% (10 of 40) - all of these men belonged to the group of individuals with masked hypertension. After 5 years, the stress test was positive in the same men as in the first survey, which indicates the constancy of stress reactivity hemodynamics.

Conclusions: The incidence of hypertension in individuals with masked hypertension within 5 years is 25%. Application of a stress test "Mathematical account" allows to diagnose in the early stages of hemodynamic changes and start timely prevention. Stress-reactivity is stable hemodynamic changes in the cardiovascular system and in the presence of additional risk factors such as smoking, hypercholesterolemia, and abdominal obesity, realized within five years hypertension.

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are